BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19531008)

  • 1. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology.
    McGuinness RP; Proctor JM; Gallant DL; van Staden CJ; Ly JT; Tang FL; Lee PH
    Comb Chem High Throughput Screen; 2009 Sep; 12(8):812-23. PubMed ID: 19531008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
    Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
    Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free cell-based assays for GPCR screening.
    Fang Y; Frutos AG; Verklereen R
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):357-69. PubMed ID: 18537557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
    Peters MF; Knappenberger KS; Wilkins D; Sygowski LA; Lazor LA; Liu J; Scott CW
    J Biomol Screen; 2007 Apr; 12(3):312-9. PubMed ID: 17307886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free impedance-based whole cell assay to study GPCR pharmacology.
    Doornbos MLJ; Heitman LH
    Methods Cell Biol; 2019; 149():179-194. PubMed ID: 30616818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.
    Lee PH
    J Recept Signal Transduct Res; 2009; 29(3-4):146-53. PubMed ID: 19594401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
    Yu N; Atienza JM; Bernard J; Blanc S; Zhu J; Wang X; Xu X; Abassi YA
    Anal Chem; 2006 Jan; 78(1):35-43. PubMed ID: 16383308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP assays in GPCR drug discovery.
    Vasudevan NT
    Methods Cell Biol; 2017; 142():51-57. PubMed ID: 28964339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GloSensor assay for discovery of GPCR-selective ligands.
    Kumar BA; Kumari P; Sona C; Yadav PN
    Methods Cell Biol; 2017; 142():27-50. PubMed ID: 28964338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
    Peters MF; Scott CW
    J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free whole-cell assays: expanding the scope of GPCR screening.
    Scott CW; Peters MF
    Drug Discov Today; 2010 Sep; 15(17-18):704-16. PubMed ID: 20601093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis.
    Ciambrone GJ; Liu VF; Lin DC; McGuinness RP; Leung GK; Pitchford S
    J Biomol Screen; 2004 Sep; 9(6):467-80. PubMed ID: 15452333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors.
    Lee PH; Gao A; van Staden C; Ly J; Salon J; Xu A; Fang Y; Verkleeren R
    Assay Drug Dev Technol; 2008 Feb; 6(1):83-94. PubMed ID: 18336088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists.
    Zhu Y; Watson J; Chen M; Shen DR; Yarde M; Agler M; Burford N; Alt A; Jayachandra S; Cvijic ME; Zhang L; Dyckman A; Xie J; O'Connell J; Banks M; Weston A
    J Biomol Screen; 2014 Aug; 19(7):1079-89. PubMed ID: 24789006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells.
    Fang Y; Li G; Ferrie AM
    J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High content screening for G protein-coupled receptors using cell-based protein translocation assays.
    Grånäs C; Lundholt BK; Heydorn A; Linde V; Pedersen HC; Krog-Jensen C; Rosenkilde MM; Pagliaro L
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):301-9. PubMed ID: 16101006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors.
    Verdonk E; Johnson K; McGuinness R; Leung G; Chen YW; Tang HR; Michelotti JM; Liu VF
    Assay Drug Dev Technol; 2006 Oct; 4(5):609-19. PubMed ID: 17115931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
    Dogra S; Sona C; Kumar A; Yadav PN
    Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool.
    Doijen J; Van Loy T; Landuyt B; Luyten W; Schols D; Schoofs L
    Biosens Bioelectron; 2019 Jul; 137():33-44. PubMed ID: 31077988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.